IGM Biosciences, Inc.
IGMSDelisted Aug 14, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001496323
IGM Biosciences, Inc. was delisted on Aug 14, 2025; its insiders filed their last Form 4 on Aug 18, 2025; 66 institutions reported holding it in 13F filings for Q2 2025, worth $17.9M in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding IGM Biosciences, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 82 | 2 | 72 | −8 |
| Shares | 22.3M | 899.1K | 21.6M | +188.8K (+0.9%) |
| Value | $152.9M | $6.18M | $356.6M | +$209.8M (+142.9%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held IGM Biosciences, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Siren, L.L.C. | 3,330,422 | $55.1M | 2.76% |
| BlackRock, Inc. | 899,921 | $14.9M | 0.00% |
| Invesco Ltd. | 222,928 | $3.69M | 0.00% |
| Susquehanna International Group, LLP | 19,467 | $322.0K | 0.00% |
| Cerity Partners LLC | 10,500 | $173.7K | 0.00% |
| MetLife Investment Management | 8,997 | $148.8K | 0.00% |
| Smartleaf Asset Management LLC | 434 | $7.38K | 0.00% |
| Lindbrook Capital, LLC | 185 | $3.06K | 0.00% |
| Versant Capital Management, Inc | 169 | $2.79K | 0.00% |
| GAMMA Investing LLC | 69 | $1.14K | 0.00% |
| Sterling Capital Management LLC | 18 | $298 | 0.00% |
Sold out (19)
Institutions that held IGM Biosciences, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Artal Group S.A. | 3,330,422 | $22.9M |
| Samsara BioCapital, LLC | 154,664 | $1.06M |
| Marshall Wace, LLP | 107,267 | $736.9K |
| ExodusPoint Capital Management, LP | 71,503 | $491.0K |
| Pennant Investors, LP | 64,900 | $445.9K |
| Hudson Bay Capital Management LP | 46,119 | $316.8K |
| Point72 Asset Management, L.P. | 27,246 | $187.2K |
| Verition Fund Management LLC | 26,120 | $179.4K |
| Panagora Asset Management Inc | 23,406 | $160.8K |
| XTX Topco Ltd | 20,408 | $140.2K |
| Jump Financial, LLC | 19,200 | $131.9K |
| American Century Companies Inc | 16,798 | $115.4K |
| Tudor Investment Corp Et Al | 14,537 | $99.9K |
| AQR Capital Management LLC | 12,230 | $84.0K |
| Cubist Systematic Strategies, LLC | 3,300 | $22.7K |
| Citadel Advisors LLC | 1,979 | $13.6K |
| Group One Trading, L.P. | 304 | $2.09K |
| Quarry LP | 197 | $1.35K |
| Advisor Group Holdings, Inc. | 59 | $405 |
Not filed for Q3 2024 yet (2)
Institutions that held IGM Biosciences, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 883,081 | $6.07M |
| Susquehanna Fundamental Investments, LLC | 16,028 | $110.1K |